Review



human ovarian carcinoma cell line skov3  (Procell Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Procell Inc human ovarian carcinoma cell line skov3
    Human Ovarian Carcinoma Cell Line Skov3, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ovarian carcinoma cell line skov3/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    human ovarian carcinoma cell line skov3 - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    skov3 human ovarian carcinoma cell line  (ATCC)
    99
    ATCC skov3 human ovarian carcinoma cell line
    6-gingerol induces apoptosis in <t>SKOV3</t> cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.
    Skov3 Human Ovarian Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/skov3 human ovarian carcinoma cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    skov3 human ovarian carcinoma cell line - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    human serous epithelial ovarian carcinoma cell line skov3  (China Center for Type Culture Collection)
    90
    China Center for Type Culture Collection human serous epithelial ovarian carcinoma cell line skov3
    6-gingerol induces apoptosis in <t>SKOV3</t> cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.
    Human Serous Epithelial Ovarian Carcinoma Cell Line Skov3, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human serous epithelial ovarian carcinoma cell line skov3/product/China Center for Type Culture Collection
    Average 90 stars, based on 1 article reviews
    human serous epithelial ovarian carcinoma cell line skov3 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    skov3 ddp human ovarian carcinoma cell lines  (ATCC)
    99
    ATCC skov3 ddp human ovarian carcinoma cell lines
    6-gingerol induces apoptosis in <t>SKOV3</t> cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.
    Skov3 Ddp Human Ovarian Carcinoma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/skov3 ddp human ovarian carcinoma cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    skov3 ddp human ovarian carcinoma cell lines - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    human ovarian carcinoma cell line skov3  (Procell Inc)
    90
    Procell Inc human ovarian carcinoma cell line skov3
    6-gingerol induces apoptosis in <t>SKOV3</t> cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.
    Human Ovarian Carcinoma Cell Line Skov3, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ovarian carcinoma cell line skov3/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    human ovarian carcinoma cell line skov3 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cell line species type purpose skov3 human ovarian carcinoma candidate skbr3 human breast carcinoma candidate c6 rat glioma control  (ATCC)
    99
    ATCC cell line species type purpose skov3 human ovarian carcinoma candidate skbr3 human breast carcinoma candidate c6 rat glioma control
    6-gingerol induces apoptosis in <t>SKOV3</t> cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.
    Cell Line Species Type Purpose Skov3 Human Ovarian Carcinoma Candidate Skbr3 Human Breast Carcinoma Candidate C6 Rat Glioma Control, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell line species type purpose skov3 human ovarian carcinoma candidate skbr3 human breast carcinoma candidate c6 rat glioma control/product/ATCC
    Average 99 stars, based on 1 article reviews
    cell line species type purpose skov3 human ovarian carcinoma candidate skbr3 human breast carcinoma candidate c6 rat glioma control - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    human ovarian carcinoma cell line skov3 procell cl-0215  (Procell Inc)
    90
    Procell Inc human ovarian carcinoma cell line skov3 procell cl-0215
    6-gingerol induces apoptosis in <t>SKOV3</t> cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.
    Human Ovarian Carcinoma Cell Line Skov3 Procell Cl 0215, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ovarian carcinoma cell line skov3 procell cl-0215/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    human ovarian carcinoma cell line skov3 procell cl-0215 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ovca cell line skov3  (OriGene)
    92
    OriGene ovca cell line skov3
    6-gingerol induces apoptosis in <t>SKOV3</t> cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.
    Ovca Cell Line Skov3, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ovca cell line skov3/product/OriGene
    Average 92 stars, based on 1 article reviews
    ovca cell line skov3 - by Bioz Stars, 2026-03
    92/100 stars
    		  Buy from Supplier
    human ovarian carcinoma cell lines skov3, 2008c13, ovcar3, and a2780s  (Pasteur Institute)
    90
    Pasteur Institute human ovarian carcinoma cell lines skov3, 2008c13, ovcar3, and a2780s
    6-gingerol induces apoptosis in <t>SKOV3</t> cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.
    Human Ovarian Carcinoma Cell Lines Skov3, 2008c13, Ovcar3, And A2780s, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ovarian carcinoma cell lines skov3, 2008c13, ovcar3, and a2780s/product/Pasteur Institute
    Average 90 stars, based on 1 article reviews
    human ovarian carcinoma cell lines skov3, 2008c13, ovcar3, and a2780s - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    6-gingerol induces apoptosis in SKOV3 cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.

    Journal: Frontiers in Oncology

    Article Title: 6-gingerol promotes apoptosis of ovarian cancer cells through miR-506/Gli3 signaling pathway activation

    doi: 10.3389/fonc.2025.1547771

    Figure Lengend Snippet: 6-gingerol induces apoptosis in SKOV3 cells. (a) Clonogenic survival assay showing the survival rates of SKOV3 cells treated with 5 µM,10 µM,15 µM and 20 µM 6-gingerol for different durations (1 st , 2 nd , 4 th , and 6 th days). Results are based on independent experiments (n = 3). (b) Western blot analysis of cleaved caspase-3 or and cleaved PARP levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as the loading control. (c) Flow cytometry analysis of apoptosis in SKOV3 cells treated with different 6-gingerol concentrations, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (d) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (c) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001. (e) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 20 µM Z-VAD-FMK (Selleck Chemicals) for 2 hours, followed by treatment with 20 µM 6-gingerol and treated with 20 µM 6-gingerol directly for 2 days, using an Annexin V-FITC & propidium iodide (PI) apoptosis kit. Results are from three independent experiments (n = 3). (f) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel **P < 0.01, ***P < 0.001 (e) . Results are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.001.

    Article Snippet: The SKOV3 human ovarian carcinoma cell line was obtained and authenticated by the American Type Culture Collection (Manassas, VA, USA).

    Techniques: Clonogenic Cell Survival Assay, Western Blot, Control, Flow Cytometry

    6-gingerol inhibits SKOV3 cells by reducing Gli3 expression. (a) Western blot analysis showing Gli3 protein levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as a loading control. (b) Western blot analysis of apoptosis-related proteins (Bcl-xL, anti-Bcl-2, and Bax) in SKOV3 cells treated with 6-gingerol. Tubulin was used as a loading control.

    Journal: Frontiers in Oncology

    Article Title: 6-gingerol promotes apoptosis of ovarian cancer cells through miR-506/Gli3 signaling pathway activation

    doi: 10.3389/fonc.2025.1547771

    Figure Lengend Snippet: 6-gingerol inhibits SKOV3 cells by reducing Gli3 expression. (a) Western blot analysis showing Gli3 protein levels in SKOV3 cells treated with 6-gingerol. Tubulin was used as a loading control. (b) Western blot analysis of apoptosis-related proteins (Bcl-xL, anti-Bcl-2, and Bax) in SKOV3 cells treated with 6-gingerol. Tubulin was used as a loading control.

    Article Snippet: The SKOV3 human ovarian carcinoma cell line was obtained and authenticated by the American Type Culture Collection (Manassas, VA, USA).

    Techniques: Expressing, Western Blot, Control

    6-gingerol increases microRNA (miR)-506 expression in SKOV3 cells. RT-PCR analysis showing the expression levels of candidate microRNAs predicted to target Gli3 in SKOV3 cells treated with 6-gingerol. Data are normalized to the levels of 5s rRNA.

    Journal: Frontiers in Oncology

    Article Title: 6-gingerol promotes apoptosis of ovarian cancer cells through miR-506/Gli3 signaling pathway activation

    doi: 10.3389/fonc.2025.1547771

    Figure Lengend Snippet: 6-gingerol increases microRNA (miR)-506 expression in SKOV3 cells. RT-PCR analysis showing the expression levels of candidate microRNAs predicted to target Gli3 in SKOV3 cells treated with 6-gingerol. Data are normalized to the levels of 5s rRNA.

    Article Snippet: The SKOV3 human ovarian carcinoma cell line was obtained and authenticated by the American Type Culture Collection (Manassas, VA, USA).

    Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction

    miR-506 suppresses Gli3 and induces apoptosis in SKOV3 cells. (a) Flow cytometry analysis of apoptosis in SKOV3 cells after transfection with miR-506, using Annexin V-FITC and propidium iodide (PI) staining. Results are based on three independent experiments (n = 3). (b) Quantification of apoptotic cells from panel (a) . The data show the percentage of double-positive Annexin V and PI cells. Results are presented as mean ± SD (n = 3). ** P < 0.01. (c) Western blot analysis showing Gli3 protein levels. Tubulin was used as a loading control.

    Journal: Frontiers in Oncology

    Article Title: 6-gingerol promotes apoptosis of ovarian cancer cells through miR-506/Gli3 signaling pathway activation

    doi: 10.3389/fonc.2025.1547771

    Figure Lengend Snippet: miR-506 suppresses Gli3 and induces apoptosis in SKOV3 cells. (a) Flow cytometry analysis of apoptosis in SKOV3 cells after transfection with miR-506, using Annexin V-FITC and propidium iodide (PI) staining. Results are based on three independent experiments (n = 3). (b) Quantification of apoptotic cells from panel (a) . The data show the percentage of double-positive Annexin V and PI cells. Results are presented as mean ± SD (n = 3). ** P < 0.01. (c) Western blot analysis showing Gli3 protein levels. Tubulin was used as a loading control.

    Article Snippet: The SKOV3 human ovarian carcinoma cell line was obtained and authenticated by the American Type Culture Collection (Manassas, VA, USA).

    Techniques: Flow Cytometry, Transfection, Staining, Western Blot, Control

    6-gingerol induces apoptosis in SKOV3 cells via miR-506. (a) Clonogenic survival assay showing the percentage of SKOV3 cells surviving after treatment with 20 μM 6-gingerol or 20 μM 6-gingerol + antago-miR-506 over different time points (days 1, 2, 4, 6, and 8). Results are based on three independent experiments (n = 3). (b) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 6-gingerol or 6-gingerol + antago-miR-506 using Annexin V-FITC and propidium iodide (PI) staining (n = 3) # P > 0.05, *** P < 0.001. (c) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (b) . Results are presented as mean ± SD (n = 3). ***P < 0.001, #P > 0.05. (d) Western blot was performed with anti-Gli3 antibody. Tubulin was used as a loading control.

    Journal: Frontiers in Oncology

    Article Title: 6-gingerol promotes apoptosis of ovarian cancer cells through miR-506/Gli3 signaling pathway activation

    doi: 10.3389/fonc.2025.1547771

    Figure Lengend Snippet: 6-gingerol induces apoptosis in SKOV3 cells via miR-506. (a) Clonogenic survival assay showing the percentage of SKOV3 cells surviving after treatment with 20 μM 6-gingerol or 20 μM 6-gingerol + antago-miR-506 over different time points (days 1, 2, 4, 6, and 8). Results are based on three independent experiments (n = 3). (b) Flow cytometry analysis of apoptosis in SKOV3 cells treated with 6-gingerol or 6-gingerol + antago-miR-506 using Annexin V-FITC and propidium iodide (PI) staining (n = 3) # P > 0.05, *** P < 0.001. (c) Quantification of apoptotic cells (double-positive for PI and Annexin V) from panel (b) . Results are presented as mean ± SD (n = 3). ***P < 0.001, #P > 0.05. (d) Western blot was performed with anti-Gli3 antibody. Tubulin was used as a loading control.

    Article Snippet: The SKOV3 human ovarian carcinoma cell line was obtained and authenticated by the American Type Culture Collection (Manassas, VA, USA).

    Techniques: Clonogenic Cell Survival Assay, Flow Cytometry, Staining, Western Blot, Control